Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Diffusion Pharmaceuticals (DFFN) stocks

Learn how to easily invest in Diffusion Pharmaceuticals stocks.

Diffusion Pharmaceuticals is a biotechnology business based in the US. Diffusion Pharmaceuticals stocks (DFFN.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.7422 – a decrease of 3.26% over the previous week. Diffusion Pharmaceuticals employs 13 staff and has a market cap (total outstanding stock value) of $7.9 million.

How to buy Diffusion Pharmaceuticals stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – DFFN. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Promoted for Beginners


National Bank Direct Brokerage

  • Commission-free trading
  • Several account types available
  • Access to array of research tools

Promoted for Low Fees

CIBC Investor's Edge

  • Easy to use platform
  • Low fees
  • Student and young investor discounts

Best for Lowest Commissions

Finder Award

Interactive Brokers

  • Access to international stock exchanges
  • Low margin rates
  • Powerful research tools

Diffusion Pharmaceuticals stock price (NASDAQ:DFFN)

Use our graph to track the performance of DFFN stocks over time.

Diffusion Pharmaceuticals shares at a glance

Information last updated 2023-05-26.
Latest market close$3.86
52-week range$3.65 - $8.85
50-day moving average $4.35
200-day moving average $5.52
Wall St. target price$40.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-7.28

Buy Diffusion Pharmaceuticals stocks from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 5 of 5
Name Product Finder Rating Available Asset Types Stock Trading Fee Account Fee Signup Offer Table description
National Bank Direct Brokerage
Finder Rating:
4.2 / 5
Stocks, Bonds, Options, Mutual Funds, GICs
$0 if conditions met, or $100
Get $0 commission on all transactions with promo code: finder
CIBC Investor's Edge
Finder Rating:
3.8 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs
$0 if conditions met, or $100
An easy-to-use platform with access to a variety of tools to help you trade with confidence.
Interactive Brokers
Finder Rating:
4.3 / 5
Stocks, Bonds, Options, ETFs, Currencies, Futures
min $1.00, max 0.5%
Winner for Best Overall Broker in the Finder Stock Trading Platform Awards.
Finder Rating:
4.3 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$4.95 - $9.95
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio to take out some of the guesswork.
Qtrade Direct Investing
Finder Rating:
3.7 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Get up to $150 sign-up bonus. Use promo code BONUS150. Conditions apply. Ends June 30, 2023.
Low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options.

Is it a good time to buy Diffusion Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Diffusion Pharmaceuticals price performance over time

Historical closes compared with the close of $3.86 from 2023-05-26

1 week (2023-05-19) -3.26%
1 month (2023-04-27) -0.77%
3 months (2023-02-27) -34.01%
6 months (2022-11-25) -37.44%
1 year (2022-05-25) -49.41%
2 years (2021-05-27) 467.65%
3 years (2020-05-27) 219.01%
5 years (2018-05-25) 656.86%
[/expander_content] [/expander]

Diffusion Pharmaceuticals financials

Gross profit TTM $0
Return on assets TTM -37.72%
Return on equity TTM -64.64%
Profit margin 0%
Book value $7.98
Market capitalisation $7.9 million

TTM: trailing 12 months

Diffusion Pharmaceuticals share dividends

We're not expecting Diffusion Pharmaceuticals to pay a dividend over the next 12 months.

Have Diffusion Pharmaceuticals's shares ever split?

Diffusion Pharmaceuticals's shares were split on a 1:50 basis on 19 April 2022. So if you had owned 50 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Diffusion Pharmaceuticals shares – just the quantity. However, indirectly, the new 4900% higher share price could have impacted the market appetite for Diffusion Pharmaceuticals shares which in turn could have impacted Diffusion Pharmaceuticals's share price.

Diffusion Pharmaceuticals share price volatility

Over the last 12 months, Diffusion Pharmaceuticals's shares have ranged in value from as little as $3.65 up to $8.85. A popular way to gauge a stock's volatility is its "beta".

DFFN.US volatility(beta: 1.8)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Diffusion Pharmaceuticals's is 1.8044. This would suggest that Diffusion Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Diffusion Pharmaceuticals overview

Diffusion Pharmaceuticals Inc. , a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. The company was founded in 2001 and is based in Charlottesville, Virginia. .

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site